Article
Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
The Journal of biological chemistry - 5 Oct 1990
Kagimoto M, Heim M, Kagimoto K, Zeugin T, Meyer U A
Abstract excerpt
The debrisoquine/sparteine-type polymorphism is a clinically important inherited variation of drug metabolism characterized by two phenotypes, the extensive metabolizer and the poor metabolizer (PM). Five to 10 percent of individuals in Caucasian populations are of the PM phenotype and have deficient metabolism of debrisoquine and over 25 other drugs. Our previous studies have revealed absence of cytochrome...
Topics
- Alleles
- Base Sequence
- Chimera
- Cloning, Molecular
- Cytochrome P-450 Enzyme System
- DNA
- Debrisoquin
- Exons
- Gene Expression
- Genes
- Humans
